Quanxing Liu

11PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 14, 2026
C1ORF112 drives lung adenocarcinoma progression through e2f8-mediated transcriptional activation.

|Jun 17, 2026
Artificial intelligence-assisted early screening of lung cancer and accurate diagnosis of pulmonary nodules: research progress and clinical prospects from radiomics to multi-omics integration: a narrative review.

|Jun 15, 2026
PYCR1 promotes glutamine metabolism and the progression of lung adenocarcinoma by regulating the expression of OPLAH.

|Jun 10, 2026
Biomimetic Shell-Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer.

|May 30, 2026
ABCC2 as a novel therapeutic target in lung adenocarcinoma: a machine learning-driven discovery linking ammonia metabolism to prognosis and drug resistance.

|May 25, 2026
Postoperative radiotherapy improves overall survival and was not associated with a statistically significant increase in cardiac-specific mortality in thymoma patients: a propensity score-matched analysis of the SEER database.

Pageof 2

Frequent Collaborators

6 joint publications

Jigang Dai

3 joint publications

Peng Dai

2 joint publications

Xiaobing Liu

1 joint publications

Renyu Wang